AZ’s Imfinzi approved in early lung cancer in China

AZ’s Imfinzi approved in early lung cancer in China

Source: 
Pharmaforum
snippet: 

The Chinese regulator has approved AstraZeneca’s Imfinzi in an early form of lung cancer after treatment with chemotherapy and radiation.